Source: BioPortfolio

PanOptica: PanOptica Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 10052018 Prices from USD $250

SummaryPanOptica Inc PanOptica is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and devel...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Paul G. Chaney's photo - President & CEO of PanOptica

President & CEO

Paul G. Chaney

CEO Approval Rating

87/100

Read more